The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma
- 9 September 2020
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 34 (2), 327-335
- https://doi.org/10.1038/s41379-020-00669-7
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Mapping of Chromosome 1p Deletions in Myeloma Identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as Being Genes in Regions Associated with Adverse SurvivalClinical Cancer Research, 2011
- A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trialLeukemia, 2011
- The prognostic significance of cytogenetics and molecular profiling in multiple myelomaCancer Genetics, 2011
- Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose ChemotherapyTransplantation and Cellular Therapy, 2010
- CKS1B nuclear expression is inversely correlated with p27Kip1 expression and is predictive of an adverse survival in patients with multiple myelomaHaematologica, 2010
- 1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myelomaBone Marrow Transplantation, 2009
- Chromosome 1p21 deletion is a novel prognostic marker in patients with multiple myelomaBritish Journal of Haematology, 2007
- CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanismsBlood, 2007
- Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myelomaLeukemia, 2006
- Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantationBlood, 2006